Sotagliflozin D3

Product Name Sotagliflozin D3
CAT No. CS-O-16626
CAS No. 1018899-04-1 (Unlabeled)
Category Stable Isotopes
Stock IN-Stock
Mol. Wt. 427.96 g/mol
Mol. For. C₂₁H₂₂D₃ClO₅S
Hazardous This is a Hazardous Compound
COA View Sample COA
MSDS View Sample MSDS
Therapeutic Anti-Diabetic
Smileys O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](SC([2H])([2H])[2H])[C@@H](O)[C@@H]1O
Canonical Smiles CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl
InchIKey QKDRXGFQVGOQKS-CRSSMBPESA-N
Inchl InChI=1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1
IUPAC (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol
Controlled No
Shipping Free for purchase above 1000$
Delivery In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries.
Return Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product).
Ordering Place your order online or by email sales@clearsynth.com
Sotagliflozin D3 is a drug that is used to treat type 1 and type 2 diabetes. It works by inhibiting two types of glucose transporters in the body, SGLT1 and SGLT2. SGLT1 is responsible for glucose absorption in the gastrointestinal tract, while SGLT2 is responsible for glucose reabsorption in the kidneys. By inhibiting these transporters, sotagliflozin D3 decreases glucose absorption and increases glucose excretion in the urine, leading to lower blood glucose levels. Sotagliflozin D3 is typically taken orally in tablet form, with or without food. The dosage and duration of treatment will depend on the individual's medical history, response to treatment, and other factors such as age and weight. It is important to follow the prescribing doctor's instructions carefully to ensure safe and effective treatment. Chemically, sotagliflozin D3 is a deuterated version of sotagliflozin, a drug that was approved by the FDA in 2019 for use in adults with type 1 diabetes. Deuterium is an isotope of hydrogen that has an extra neutron in its nucleus, making it slightly heavier than regular hydrogen. This modification can enhance the drug's metabolic stability and improve its pharmacokinetic properties, leading to better efficacy and safety. Sotagliflozin D3 is still undergoing clinical trials to determine its effectiveness and safety in treating diabetes.

This page contains information about Sotagliflozin D3. You can buy Sotagliflozin D3 from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Sotagliflozin D3